| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |